Health CanadaGeneral Alert
New restrictions on the use of rosiglitazone products due to cardiac safety concerns (Avandia, Avandamet, Avandaryl) - For Health Professionals
Published: November 6, 2007Recall ID: 24241Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
New restrictions on the use of rosiglitazone products due to cardiac safety concerns (Avandia, Avandamet, Avandaryl) - For Health Professionals
Recalling Firm: Marketed health products
Product Description & Identification
New restrictions on the use of rosiglitazone products due to cardiac safety concerns (Avandia, Avandamet, Avandaryl) - For Health Professionals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24241 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/new-restrictions-use-rosiglitazone-products-due-cardiac-safety-concerns-avandia |
| Title | New restrictions on the use of rosiglitazone products due to cardiac safety concerns (Avandia, Avandamet, Avandaryl) - For Health Professionals |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2007-11-06 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - New restrictions on the use of rosiglitazone products due to cardiac safety concerns (Avandia, Avandamet, Avandaryl) - For Health Professionals Check if your household is affected: https://therecallfile.com/recalls/new-restrictions-on-the-use-of-rosiglitazone-products-due-to-cardiac-s/CANADA-24241
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordNew restrictions on the use of rosiglitazone products due to cardiac safety concerns (Avandia, Avandamet, Avandaryl) - For Health Professionals